AEON vs AMZN · P/E 0.0, $8.6M cap vs P/E 31, rev $716.92B
AEON Biopharma, Inc. (AEON) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
AEON does not have a complete income-statement cache yet.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the AEON and AMZN stock pages for the full models.
Not investment advice.